Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-(1-7) complexed with hydroxypropyl beta cyclodextrin plus home-based isometric exercise for muscle loss in older adults
RBR-5ky68scRecruiting
- Sponsor
- Universidade Federal de Ouro Preto
- Start
- Feb 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of angiotensin-(1-7) in muscle atrophy and Sarcopenia (2 arms), sponsored by Universidade Federal de Ouro Preto. Started Feb 2026; status: recruiting.
02
Drugs
angiotensin-(1-7)
03
Conditions
muscle atrophySarcopenia
Beyond the preview
Go deeper on RBR-5ky68sc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5ky68sc.